Response to Transdermal Selegiline Smoking Cessation Therapy and Markers in the 15q24 Chromosomal Region

Nicotine and Tobacco Research - United Kingdom
doi 10.1093/ntr/ntu273
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Oxford University Press (OUP)

Related search

Identification of Pharmacogenetic Markers in Smoking Cessation Therapy

American Journal of Medical Genetics, Part B, Neuropsychiatric Genetics
PsychiatryMolecular NeuroscienceMental HealthGeneticsCellular
2007English

Smoking Cessation: A Clinical Study of the Transdermal Nicotine Patch

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1995English

Smoking Cessation: Relapse and Therapy

Güncel Göğüs Hastalıkları Serisi
2017English

The Effects of Transdermal Nicotine Therapy for Smoking Cessation on Depressive Symptoms in Patients With Major Depression

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
2001English

The Search for Individualized Smoking Cessation Therapy

Jornal Brasileiro de Pneumologia
PulmonaryRespiratory Medicine
2017English

Divergence by ADHD Subtype in Smoking Cessation Response to OROS-Methylphenidate

Nicotine and Tobacco Research
EnvironmentalPublic HealthOccupational Health
2011English

Nicotine Metabolic Rate Predicts Successful Smoking Cessation With Transdermal Nicotine: A Validation Study

Pharmacology Biochemistry and Behavior
PharmacologyBiochemistryClinical BiochemistryBehavioral NeuroscienceToxicologyBiological Psychiatry
2009English

Clinical Effectiveness of Smoking Cessation Therapy During Pregnancy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Extended Cognitive Behavior Therapy for Cigarette Smoking Cessation

Addiction
MedicinePsychiatryMental Health
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy